Back to top

Director’s Bold Move: Major Stock Purchase at Galectin Therapeutics!

New insider activity at Galectin Therapeutics ( ($GALT) ) has taken place on July 18, 2025. Director Kevin D. Freeman has recently acquired 5,000 s...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Galectin Therapeutics Inc. (GALT)